Digital Brain Twin Technology Improved Epilepsy Surgery

Researchers used a personalized brain twin to better identify seizure epicenters for drug-resistant epilepsy patients.

Updated on Sept. 29, 2026 in Alzheimer’s

Isometric editorial illustration of a translucent glass human brain model with a single highlighted neural area, evoking medical research.
Researchers at Aix-Marseille University have developed a digital brain twin technology that improves surgical precision for patients with drug-resistant epilepsy. AI Illustration. Upload story photo >

Live Poll

Do you trust digital brain modeling technology to improve the accuracy of complex surgical procedures?

A digital twin platform called BrainXplore, developed after 25 years of research at Aix-Marseille University, demonstrated an 84% success rate in identifying seizure epicenters during a 2018 study. This technology aims to assist in planning surgical interventions for the 30% of epilepsy patients who are drug-resistant.

Why it matters

Current epilepsy surgeries have failure rates as high as 40%, leaving many patients with few options for managing their condition. This digital approach seeks to improve surgical precision by providing clearer mapping of seizure zones before surgeons operate.

A 2018 trial of 53 patients demonstrated an 84% success rate for seizure epicenter identification using the BrainXplore platform. A larger trial involving 350 patients was completed in 2025, though final findings are pending.

The players

VB-Tech

A developer of digital medical technologies that creates virtual brain simulations to assist in neurosurgical planning.

Aix-Marseille University

A French research institution that conducted 25 years of foundational studies supporting this digital brain modeling.

The details

The BrainXplore platform creates a digital twin by integrating individual neuroimaging and patient data with mathematical equations. This model identifies the precise location of seizure epicenters within the brain. The technology is intended to refine or replace current planning methods like stereoelectroencephalography (SEEG), which are used to guide surgical teams.

Timeline

  1. 2018: A trial involving 53 patients was conducted.

  2. 2019: A large-scale trial involving 350 patients began.

  3. 2025: The large-scale clinical trial concluded.

  4. 2027: Target date for official product certification.

  5. 2028: Planned date for widespread hospital rollout.

Health Landscape

This development represents a shift toward digital modeling in neurosurgery, moving away from relying solely on standard stereoelectroencephalography. It reflects a broader trend of using computational twins to increase the precision of invasive procedures for complex neurological conditions.

If you or a family member manage drug-resistant epilepsy, this technology may eventually offer a new pathway to increase surgical success. These developments should be discussed with a neurologist or neurosurgeon to understand if future digital mapping may be applicable to your care plan.

The takeaway

Digital brain modeling is emerging as a potential tool to increase the success of epilepsy surgery by providing surgeons with more accurate mapping. Patients should continue to monitor medical advancements and consult with their surgical team regarding new planning technologies as they become available.

Further reading

For broader updates on neuro-mapping technology, see our Alzheimer’s section.

Source note: This article includes information reported by The Connexion - Expatriate News.

Live Poll

Do you trust digital brain modeling technology to improve the accuracy of complex surgical procedures?